Paraneoplastic Guillain-Barré Syndrome in Small Cell Lung Cancer

Guillain-Barré syndrome (GBS) is defined as an acute, autoimmune polyradiculoneuropathy. It is a rare disease that occurs at a rate of 1.11 cases per 100,000 person-years. However, once infected, up to 20%percnt; of patients develop severe disability, and approximately 5%percnt; die. There have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Moon Ho, Hwang, Min Sik, Park, Yoon Kyoo, Park, Yerim, Ahn, Yong Chel, Oh, Ho-Suk, Ahn, Heui-June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: July, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560330/
https://www.ncbi.nlm.nih.gov/pubmed/26351437
http://dx.doi.org/10.1159/000437295
Descripción
Sumario:Guillain-Barré syndrome (GBS) is defined as an acute, autoimmune polyradiculoneuropathy. It is a rare disease that occurs at a rate of 1.11 cases per 100,000 person-years. However, once infected, up to 20%percnt; of patients develop severe disability, and approximately 5%percnt; die. There have been reports of GBS in different cancers. Among them, there are 6 previous reports of GBS in small cell lung cancer. Here, we report a case of a 52-year-old man who was diagnosed with GBS in the setting of small cell lung cancer with chemotherapy.

Ejemplares similares